Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Agamree 40 mg/ml, Suspension zum Einnehmen 100
Drug
Agamree, Suspension zum Einnehmen
Behandlung von Duchenne-Muskeldystrophie
01.99.0. – various
HAM – Human medicine
SUOR – Oral suspension
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
1/14/2026
1/13/2031
Dosage strength
Agamree 40 mg/ml, Suspension zum Einnehmen
Behandlung von Duchenne-Muskeldystrophie
01
Z – approved
Package
No information made available
A/NR – Authorised / not referenced
100 ml
001
Z – approved
Declaration
Component
40 mg vamorolonum
sucralosum
xanthani gummi
dinatrii phosphas
acidum citricum monohydricum
1 mg E 211
50 mg glycerolum
aromatica
acidum hydrochloridum
aqua purificata
1.064 mg natrium
xanthani gummi
dinatrii phosphas
acidum citricum monohydricum
1 mg E 211
50 mg glycerolum
aromatica
acidum hydrochloridum
aqua purificata
1.064 mg natrium
Authorisation holder
Santhera Pharmaceuticals (Schweiz)
Hohenrainstrasse 24
4133 Pratteln (BL)
Hohenrainstrasse 24
4133 Pratteln (BL)
Date of the last update to the medicines data
2/1/2026
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.